Compliance-linked incentives increase infant immunizations rates in rural India

March 14, 2018

Infantile immunization rates were higher among children whose caregivers received compliance-linked incentives when compared to those who received only mobile phone reminders and those who received no intervention.

Impact of Bundled Interventions Examined for Increasing HPV Vaccination Rates

March 14, 2018

The researchers observed an increase in captured opportunities for HPV vaccination, from 46.9 to 63.3%. Centerline shift demonstrated special cause, with 8 consecutive points above the preintervention mean.

2017 Catch-Up Vaccination Schedule: 4 Months-18 Years

March 13, 2018

A catch-up immunization schedule for children 4 months to 18 years of age, including minimum intervals between doses of delayed immunizations.

Maternal Use of TDF Doesn't Further Reduce HBV Transmission

March 08, 2018

Findings in setting with low HBV transmission with administration of hepatitis B immune globulin, vaccine

Does Cumulative Vaccine Exposure in Infants Raise Risk of Certain Infections?

March 07, 2018

The matched odds ratio for estimated cumulative antigen exposure through 23 months was not significant among children with versus those without non-vaccine-targeted infections from 24 through 47 months of age.

Vaccination Outcomes of HPV Primary Care Intervention Examined

March 06, 2018

A greater effect of the intervention was seen for pediatric practices versus family medicine practices and in private practices versus public ones. According to reports from health care professionals, the most used and useful intervention components were communication training and the fact sheets.

Vaccination Coverage Among U.S.- vs. Foreign-Born Adolescents Examined

By March 02, 2018

For hepatitis B (≥3 doses), foreign-born adolescents had significantly lower coverage rates, 89.6% vs. 92.6% for U.S.-born adolescents, even after adjustments were made for demographic and socioeconomic factors.

CDC: Limited Availability of Alternative Yellow Fever Vaccine

By March 01, 2018

As part of the investigational new drug program, only a limited number of clinics can stock Stamaril.

Tourist With Measles May Have Exposed Others, Says NY State Dept of Health

By February 27, 2018

A tourist from Australia has been confirmed to have measles.

ACIP Votes in Favor of Intranasal Flu Vaccine Flumist Quadrivalent

By February 22, 2018

The Advisory Committee on Immunization Practices (ACIP) has voted in favor of a renewed recommendation for the use of Flumist Quadrivalent (Influenza Vaccine Live, Intranasal).

ACIP Recommends Use of Heplisav-B for Hepatitis B Prevention in Adults

By February 21, 2018

The Advisory Committee on Immunization Practices (ACIP) voted unanimously in favor of including Heplisav-B on its list of ACIP recommended products.

Vaccination During Pregnancy Not Linked to Infant Hospitalization, Death

February 21, 2018

There was no correlation between infant hospitalization and maternal influenza (adjusted odds ratio, 1; 95% confidence interval, 0.96 to 1.04) or Tdap (adjusted odds ratio, 0.94; 95% confidence interval, 0.88 to 1.01) vaccinations.

CDC: Elevated Flu Activity Expected to Continue for Several More Weeks

By February 16, 2018

So far this season, influenza A(H3N2) viruses have predominated, but other influenza viruses are also circulating.

Researchers Hope to Test Heroin Vaccine in Humans Soon

By February 14, 2018

Researchers investigated 20 different carrier protein/adjuvant combinations.

Conspiracy Beliefs and Anti-Vaccination Attitudes: What's the Link?

By February 07, 2018

Incidences of measles, mumps and pertussis have increased in the U.S. for the first time in a century (WHO, 2017). To identify the 'attitude roots' of vaccine rejection, a survey was issued online and completed by 5,323 usable participants in 24 different countries.

ACIP: 2018 Recommended Immunization Schedule for Adults Released

By February 06, 2018

Changes in the 2018 adult immunization schedule from the previous year's schedule include new ACIP recommendations for the use of recombinant zoster vaccine (RZV) for adults aged 50 years or older and the use of an additional dose of measles, mumps, and rubella vaccine (MMR) in a mumps outbreak setting.

ACIP: 2018 Immunization Schedule for Children, Adolescents Available

By February 06, 2018

The recommended childhood and adolescent immunization schedules for 2018 have been approved by the American Academy of Pediatrics, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC), the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.

New Formulation of HyperRAB Approved for Rabies Post-Exposure Prophylaxis

By February 06, 2018

Reduced volume of medication offers potential for fewer injections.

Patient Portal Messages, IVR Calls May Improve Flu Vaccination Rates

By February 05, 2018

Results found that among portal users, 14% (702/5,000) of portal and IVR call recipients received EHR-documented influenza vaccines.

Influenza Vaccine Recommendations: Egg Allergies

February 02, 2018

Influenza vaccine recommendations for individuals who report an allergy to eggs.

ACIP: Updated Recommendations for Mumps Vaccination

By January 16, 2018

The purpose of the recommendation is to improve protection of persons in outbreak settings against mumps disease and complications

ACIP: Updated Recommendations for Hepatitis B Virus Infection Prevention

By January 12, 2018

The Work Group who authored the new recommendations was made up of professionals from academic medicine, federal and state public health agencies, and medical societies.

FDA Approves Expanded Indication for Fluarix Quadrivalent

By January 12, 2018

The supplemental Biologics License Application was based on a Phase III pivotal study of the efficacy of Fluarix Quadrivalent in children 6 months through 35 months of age and on two supportive studies.

Over one-third of U.S. HIV patients are not vaccinated against hepatitis B

January 10, 2018

One third of HIV patients in the United States remain unvaccinated against hepatitis B.

Heplisav-B Now Available for Hepatitis B Prevention in Adults

By January 08, 2018

Heplisav-B is the first and only two-dose vaccine for prevention of hepatitis B in adults.

Cost-Effectiveness of Herpes Zoster Vaccines Compared

January 08, 2018

Compared with no vaccination, the incremental cost-effectiveness ratios ranged from $20,038 to $30,084 per quality-adjusted life-year (QALY), depending on vaccination age.

Repeat Flu Vaccination Outcomes Examined in Older Patients

January 08, 2018

"These results reinforce recommendations for annual vaccination for influenza in older adults," the authors write.

Hepatitis B Vaccination Often Missed Among HIV Patients

December 27, 2017

More than one-third of adult HIV patients receiving medical care have not been vaccinated

New Flu Vaccine Guidelines Issued for Patients With Egg Allergy

By December 19, 2017

The updated parameter stresses that no special precautions are needed or recommended for those with egg allergy.

Parental Counseling May Help Cut Vaccine Exemption Rates

December 18, 2017

Significant drop in rates in Washington after implementation of bill mandating parental counseling